scholarly journals Impact of radiation therapy on vascular endothelial adhesion receptor expression

2021 ◽  
Vol 35 (S1) ◽  
Author(s):  
Elena Wagner ◽  
Li‐Na Niu ◽  
Martha Kiljan ◽  
Olta Ibruli ◽  
Isabelle Heßelmann ◽  
...  
2006 ◽  
Vol 34 (5) ◽  
pp. 680-687 ◽  
Author(s):  
Jack Gold ◽  
Helen M. Valinski ◽  
Adrianne N. Hanks ◽  
Karen K. Ballen ◽  
Chung-Cheng Hsieh ◽  
...  

2021 ◽  
Vol 69 (8) ◽  
pp. 523-534
Author(s):  
Harim Tavares dos Santos ◽  
Kihoon Nam ◽  
Jason P. Hunt ◽  
Luke O. Buchmann ◽  
Marcus M. Monroe ◽  
...  

Radiation therapy–mediated salivary gland destruction is characterized by increased inflammatory cell infiltration and fibrosis, both of which ultimately lead to salivary gland hypofunction. However, current treatments (e.g., artificial saliva and sialagogues) only promote temporary relief of symptoms. As such, developing alternative measures against radiation damage is critical for restoring salivary gland structure and function. One promising option for managing radiation therapy–mediated damage in salivary glands is by activation of specialized proresolving lipid mediator receptors due to their demonstrated role in resolution of inflammation and fibrosis in many tissues. Nonetheless, little is known about the presence and function of these receptors in healthy and/or irradiated salivary glands. Therefore, the goal of this study was to detect whether these specialized proresolving lipid mediator receptors are expressed in healthy salivary glands and, if so, if they are maintained after radiation therapy–mediated damage. Our results indicate that specialized proresolving lipid mediator receptors are heterogeneously expressed in inflammatory as well as in acinar and ductal cells within human submandibular glands and that their expression persists after radiation therapy. These findings suggest that epithelial cells as well as resident immune cells represent potential targets for modulation of resolution of inflammation and fibrosis in irradiated salivary glands.


Blood ◽  
1997 ◽  
Vol 89 (7) ◽  
pp. 2554-2559 ◽  
Author(s):  
Lori A. Styles ◽  
Bertram Lubin ◽  
Elliott Vichinsky ◽  
Sandy Lawrence ◽  
Mandy Hua ◽  
...  

Abstract Sickle cell disease (SCD) is characterized by repeated vaso-occlusive events, which result in substantial morbidity. Abnormal adhesion of sickle red blood cells (RBC) to the vascular endothelium is postulated to play a role in the pathogenesis of vaso-occlusion. Two adhesion receptors, very late activation antigen-4 (VLA-4) and CD36, are found in unusually high numbers on sickle cell reticulocytes and do mediate adhesion of sickle RBC to endothelium. Hydroxyurea (HU) therapy results in fewer vaso-occlusive episodes, and we postulated that HU-related modulation of VLA-4 and CD36 receptors may contribute to its clinical benefit. Using flow cytometry, eight patients were followed from the onset of HU treatment through a mean treatment length of 200 ± 49 days. Mean corpuscular volume and percent fetal hemoglobin (Hb F ) increased from 87% ± 6% to 98% ± 9% and 6.6% ± 3.9% to 12.7% ± 5.6%, respectively. The percentage of reticulocytes expressing VLA-4 decreased from 29.0% ± 5.9% to 14.9% ± 2.3% (P = .0003). Two thirds of the total decrease in VLA-4 expression occurred after 10 weeks of HU and plateaued by 20 weeks. Changes in VLA-4 expression occurred before substantial increases in Hb F. The percentage of reticulocytes expressing CD36 decreased from 55.3% ± 6.4% to 42.6% (P = .0046). Changes in adhesion receptor expression were not caused by a decrease in reticulocytosis with HU therapy. This report is the first to associate a decrease in adhesion receptor expression with a therapy known to reduce the clinical severity of SCD.


Haematologica ◽  
2008 ◽  
Vol 93 (4) ◽  
pp. 502-510 ◽  
Author(s):  
M.-H. Odievre ◽  
V. Bony ◽  
M. Benkerrou ◽  
C. Lapoumeroulie ◽  
C. Alberti ◽  
...  

2010 ◽  
Vol 160 (1) ◽  
pp. 107-113 ◽  
Author(s):  
Tim Jancelewicz ◽  
Erich J. Grethel ◽  
Cheryl J. Chapin ◽  
Matthew S. Clifton ◽  
Kerilyn K. Nobuhara

Blood ◽  
2008 ◽  
Vol 112 (11) ◽  
pp. 997-997 ◽  
Author(s):  
Giovanni Migliaccio ◽  
Massimo Sanchez ◽  
Francesca Masiello ◽  
Valentina Tirelli ◽  
Katija Iliecic ◽  
...  

Abstract The maturation of erythroid cells occurs in specialized areas of the marrow in close proximity to macrophages. The mature cell, the reticulocyte, loses its association with the macrophages and egresses into the blood stream. This dynamic pattern of cellular interactions is mediated by specific adhesion receptors, such as CXCR4 (CD184), VLA- 4 (α4 integrin, CD49d) and P-selectin glycoprotein ligand-1 (PSGL-1 or CD162). Culture conditions capable to generate ex vivo human erythroblasts in numbers sufficient for transfusion have been recently established by several investigators. The aim of this study was to evaluate whether these ex vivo-generated erythroblasts would express the adhesion receptor profile required for establishing, once injected in vivo, the cellular interactions necessary to complete their maturation. For this purpose, the pattern of CD184, CD49d and CD162 expression during the maturation of human erythroblasts generated ex vivo from adult and cord blood was investigated. Erythroblasts were divided into 4 classes of maturation by cytofluorimetrical criteria based on the levels of CD36 and CD235a (glycophorin A) expression: class 1, CD36highCD235aneg (CFU-E); class 2, CD36highCD235alow (pro-erythroblasts); class 3, CD36highCD235ahigh (basophilic-polychromatic erythroblasts) and class 4, CD36lowCD235ahigh (orthochromatic erythroblasts). The transition of the different cell populations through the maturation process was tracked by cell cycle analyses and CFSE staining. Large numbers (>5 x 107) of erythroblasts were generated from as little as 10 mL of either cord- or adult blood after 10–11 days of culture in the presence of hematopoietic growth factors, dexamethasone and estradiol (Migliaccio et al, BCMD28: 169, 2002). Cord blood-derived cells remained significantly more immature than the adult blood-derived ones (e.g. 60% vs 10% in class 1). Class 1–2 cells were mostly in G1 (G1=74%, S=21% and G2=3–5%) while a large proportion of the class 3 cells were in S (G1=34–56, S=43–56% and G2=10–11%). Changes in the levels of CSFE staining indicated that class 3 cells completed one division within 24 hrs and did not divide further. On the other hand, class 1–2 cells completed one division in 24 hr and their progeny was composed both by class 1–2 and class 3 cells (in a 50% ratio). The class 1–2 progeny divided at least one more time in the following 24 hrs while the class 3 progeny did not divide progressing directly toward the mature class 4. The majority of class 1–2 cells expressed low level of CD184 (80–85% CD184dim and 15–20% CD184high) and high levels of CD49d and CD162. When these cells were induced to mature by exposure to EPO alone, they rapidly (within 24 hrs) expressed high levels of CD184 and CD49d while the expression of CD162 was reduced. By the end of 4 days of the maturation culture in the presence of EPO, most of the cells had progressed to the mature class 3–4 phenotype. These mature class 4 cells were CD184dim, CD49dlow and CD162low. Therefore, in vitro maturation of ex vivo-generated cord and adult blood erythroblasts was associated with a dynamic pattern of adhesion receptor expression. Although, the changes observed with cord and adult blood-derived erythroblasts were similar, they occurred more rapidly and with a higher magnitude in cord blood-derived cells. In conclusion, the pattern of CD184, CD49d and CD162 expressed by ex vivo-derived human erythroblasts suggests that these cells might be capable to establish proper cellular interactions and to progress in their maturation following in vivo infusion.


Sign in / Sign up

Export Citation Format

Share Document